Constant advances in neuroimaging technology have enabled the detection of abnormal brain structures that can cause epile psy or neurodevelopmental impairment and have provided op portu nities for epilepsy surgery by providing highquality informa tion about the brains of patients with pediatric epilepsy. 1,2) Ad vanced neuroimaging using multimodal procedures is an important diag nostic tool for identifying biomarkers of epileptogenesis and drugresistant epilepsy. Magnetic resonance imag ing (MRI) identi fies structural and functional changes in abnormal neuropa thologic areas with postprocessing and advanced techniques. Po sitron emission tomography (PET) and singlepho ton emission computerized tomography (SPECT) provide the information for cerebral functional changes of epileptogenic areas via brain meta bolism and blood perfusion. 3) Multimodal techni ques such as PETMRI, subtraction of interictal from ictal SPECT coregistered to MRI (SISCOM), electroencephalogra phyfunctional MRI (EEGfMRI), and magnetoencephalogra phy (MEG) can also help elucidate the func tional alterations of epileptogenic areas in epilepsy. 4) When the first unprovoked seizure occurs or newly diagnosed epilepsy is confirmed, MRI should immediately be performed because structural lesion strongly indicates drug resistance in epilepsy. The International League Against Epilepsy recently pro vided a new consensus recommendation for the use of MRI in epilepsy. The Neuroimaging Task Force recommendation sug gests the use of Harmonized Neuroimaging of Epilepsy Struc ural Sequences (HARNESSMRI) to better identify the struc tural lesions that may be in the epileptogenic region. HARNESSMRI reveals highresolution 3dimensional (3D) T1weighted imaging with isotropic millimetric voxel resolution (1 mm×1 mm×1 mm) and no interslice gap, highresolution 3D fluid attenuation inversion recovery (FLAIR) with isotropic millimetric voxel resolution (1 mm×1 mm×1 mm) and no interslice gap, and high inplane resolution 2dimensional coro nal T2weighted ima ging with submillimetric voxel resolution (0.4 mm×0.4 mm×2 mm perpendicular to the long axis of the hippocampus) and no interslice gap. 1) In patients younger than 2 years of age, it is important to consider that MRI sequences should differ due to poor myelination that appears at this time.
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In children with drugresistant focal epilepsy, epilepsy surgery is an acceptable treatment; for this purpose, epileptogenic areas should be detected as precisely as possible. For epilepsy surgery, interictal/ictal EEG, video EEG, MRI, fluorodeoxyglucose (FDG) PET, SPECT, electrocorticography, and intracranial monito ring are among the mandatory diagnostic tests used to localize epilepto genic areas. 4) FDGPET reveals a wider hypometabolism than the epileptogenic areas, possibly indicative of functional abnormali ties. Ictal/interictal SPECT reveals focal hyperperfu sion/hypoper fusion of epileptogenic areas and is more suitable than PET in that aspect. Advanced neuroimaging techniques with the potential ability to detect epileptogenic areas include PETMRI, SISCOM, EEGfMRI, EEG source imaging, MEG, MR spec troscopy, MRI postprocessing techniques, and diffusion weighted imaging with tractography. 5) EEG source imaging/ MEG helps localize epileptogenic areas as well as those with altered functional con nectivity. EEG records tangential and radial currents with tem poral resolution but has limited spatial resolution. EEG source imaging overcomes the limitations of EEG recordings in terms of temporal and spatial resolution. MEG records magnetic fields of tangential currents, which can be used for MRInegative pati ents with suspected tangential areas in which the EEG tracing is likely to be distorted. In terms of cost effectiveness, EEG source imaging may be superior to MEG, but the 2 methods are complementary. MEG and fMRI can effectively detect eloqu ent areas in children and young children, in whom clinical assessments may be difficult and very few validation studies are available. 8) Advanced neuroimaging is a challenging tool in the field of pediatric epilepsy. It is now possible to identify the epileptogenic www.e-cep.org https://doi.org/10.3345/cep.2019.01403 101 areas in nonlesional cases and increase surgical candidates. Ad vanced neuroimaging can be a prognostic factor for better sur gical outcomes that can replace invasive tests and provide infor mation about the eloquent areas, reducing functional de ficits that may arise due to excision of the eloquent areas. Ad vanced neuroimaging will be an important diagnostic tool for identifying biomarkers of epileptogenesis, altered functional connectivity, and localization of epileptogenic areas.
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